Barr executive appointments

Barr promotes Paul Bisaro to the new position of president and COO of Barr Pharmaceuticals, the company announces on Jan. 10. Bisaro, who previously served as president and COO of Barr Laboratories, has already assumed the additional responsibilities. In addition, Frederick Wilkinson will join Barr in March as president and COO of Duramed Pharmaceuticals. Wilkinson, who most recently served as CEO and president of Columbia Laboratories, will report to Bisaro. Barr is likely to make further management changes in 2006; Duramed Research COO Carole Ben-Maimon in scheduled to resign in September (1"The Pink Sheet" Jan. 2, 2006, In Brief)...